Funded Startups in Winston Salem
Disclosed financing amounts in this Winston Salem set are relatively clustered at the low single-digit millions, except for Javara Research’s $9M (2023-11-…
Disclosed financing amounts in this Winston Salem set are relatively clustered at the low single-digit millions, except for Javara Research’s $9M (2023-11-08), which is the only disclosed round above $8M and is notably larger than the next-highest disclosed amount of $8M (Fluree, 2022-10-13). At the other end, the smallest disclosed amount is $50K (CopyForward, 2022-05-12), creating a wide spread between $50K–$9M.
The rounds span 2020-06-25 (F5 Sports) through 2025-09-24 (BMI OrganBank), with several deal prints concentrated in 2022: multiple entries between 2022-01-10 and 2022-07-05. Sector- and stage-wise, health-adjacent work dominates: Healthcare/Health Care/Biotechnology appear repeatedly (e.g., mPath Health $1M on 2024-10-21; KeraVet Bio as Pre-Seed on 2023-04-04; Precise Bio as Venture - Series Unknown on 2022-07-18), while a large share of rounds are “undisclosed” or labeled “Series Unknown” (10 “undisclosed” amounts; 13 “Series Unknown” classifications).
Most recent rounds
24 shownRelated listings
Frequently asked
Which round is the biggest disclosed amount in this Winston Salem list, and how does it compare to the rest of the disclosed numbers?
Javara Research’s $9M (2023-11-08) is the largest disclosed round and sits clearly above the rest: Fluree’s $8M (2022-10-13) is the next-highest disclosed amount. Below that, the disclosed rounds run through $3M (e.g., Wake Forest Baptist Medical Center, 2022-04-12; Wellnecity, 2022-01-11) and down to the smallest disclosed $50K (CopyForward, 2022-05-12).
Is there a concentration in time, with many rounds occurring in a narrow window?
Yes, 2022 shows a dense cluster of deal dates: entries run from 2022-01-10 (BEAM Dynamics) through 2022-07-05 (Plakous Therapeutics), with additional rounds on 2022-03-21 (inStryde and XPAND Gaming) and 2022-04-06 to 2022-04-12 (Womble Bond Dickinson; Wake Forest Baptist Medical Center). The earliest date shown is 2020-06-25 (F5 Sports) and the most recent is 2025-09-24 (BMI OrganBank).
Do any sectors or company themes appear often enough to matter for prospecting?
Health-focused categories recur across multiple entries: Health Care/Healthcare and Biotechnology show up repeatedly (mPath Health in Health Care with a $1M seed on 2024-10-21; Javara Research in Health Care with $9M on 2023-11-08; KeraVet Bio in Biotechnology as Pre-Seed on 2023-04-04; Precise Bio in Biotechnology with an undisclosed amount on 2022-07-18). In contrast, several other categories appear only once (e.g., Gaming: F5 Sports, 2020-06-25; Professional Services: Womble Bond Dickinson, 2022-04-06).
What stage mix dominates, and are there notable “early-stage” and “later-stage” markers?
Seed appears frequently among disclosed rounds, including mPath Health ($1M, 2024-10-21), OrbitalRx ($860K, 2024-08-09), and Salem Cyber ($440K, 2023-02-07). Later-stage signals are present but less common in this slice: Wellnecity is the standout Series A at $3M (2022-01-11), while Venture - Series Unknown also recurs (e.g., Fluree $8M, 2022-10-13; BMI OrganBank is Venture - Series Unknown but undisclosed on 2025-09-24).
Are there outliers worth flagging for diligence based on financing size or round type?
On size, Javara Research’s $9M (2023-11-08) is the clear upper outlier among disclosed amounts, while CopyForward’s $50K (2022-05-12) is the smallest disclosed figure. On round type, the list includes non-equity/non-standard support as well (inStryde and XPAND Gaming both show Non-equity Assistance of $100K on 2022-03-21), and there are also grants/debt rounds mixed into the equity-like seed and venture entries (e.g., Womble Bond Dickinson debt financing $5M on 2022-04-06).
How much of the dataset is hard to compare because amounts or round labels are missing/unknown?
A large portion is not directly comparable on disclosed size or round classification: 10 rows list the amount as “undisclosed” (for example BMI OrganBank on 2025-09-24; Protection Plus on 2025-04-09), and 13 rows use “Series Unknown” as the round classification (for example MOMI Brands on 2025-05-16; OrbitalRx on 2024-08-09). This makes the $50K–$9M comparison apply primarily to the subset with disclosed amounts.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.